Skip to search.
 TSX Down 0.85% TSX Ventures Down 0.29%

Rigel Pharmaceuticals, Inc. (RIGL)

-NasdaqGS
2.82 Down 0.29(9.32%) Mar 3, 4:00PM EST
Add to Portfolio
Prev Close:3.11
Open:3.17
Bid:N/A
Ask:2.90 x 700
1y Target Est:6.50
Beta:2.24
Next Earnings Date:N/A
Day's Range:2.79 - 3.20
52wk Range:1.56 - 5.00
Volume:867,381
Avg Vol (3m):805,217
Market Cap:247.57M
P/E (ttm):N/A
EPS (ttm):-0.98
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
RIGLDown 9.32%247.57M
AMGNDown 0.67%120.32B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):47.48
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-1.06
Quarterly EPS Est (Mar-15) :-0.22
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, discovers and develops novel, small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback